UB Paderborn / Katalog / Suche / in CDI

Thermal dependence of large-scale freckle defect formation

Philosophical transactions of the Royal Society of London. Series A: Mathematical, physical, and engineering sciences, 2019-04, Vol.377 (2143), p.20180206-20180206

2019

Volltextzugriff (PDF)

Potential role of FLT3-ligand in the angiogenic process of multiple myeloma

Leukemia research, 2015-12, Vol.39 (12), p.1467-1472

2015

Volltextzugriff (PDF)

Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma

Leukemia research, 2012-08, Vol.36 (8), p.1004-1008

2012

Volltextzugriff (PDF)

Assessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patients

European journal of histochemistry, 2011-01, Vol.55 (3), p.e21-e21

2011

Volltextzugriff (PDF)

Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma

Annals of hematology, 2003, Vol.82 (1), p.19-23

2003

Volltextzugriff (PDF)

Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment

Mediators of Inflammation, 2011-01, Vol.2011 (2), p.867576-7

2011

Volltextzugriff (PDF)

B cell-activating factor: its clinical significance in multiple myeloma patients

Annals of hematology, 2012-09, Vol.91 (9), p.1413-1418

2012

Volltextzugriff (PDF)

Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma

Cytokine (Philadelphia, Pa.), 2011-12, Vol.56 (3), p.616-620

2011

Volltextzugriff (PDF)

Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients

Hematological oncology, 2013-12, Vol.31 (4), p.201-205

2013

Volltextzugriff (PDF)

Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma

European journal of internal medicine, 2012-06, Vol.23 (4), p.368-373

2012

Volltextzugriff (PDF)

Activated peripheral blood and endothelial cells in thalassemia patients

Annals of hematology, 2001-10, Vol.80 (10), p.577-583

2001

Volltextzugriff (PDF)

The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma

Journal of clinical pathology, 2004-08, Vol.57 (8), p.856-860

2004

Volltextzugriff (PDF)

Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity

Medical oncology (Northwood, London, England), 2015-03, Vol.32 (3), p.42-42, Article 42

2015

Volltextzugriff (PDF)

Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-α in multiple myeloma

Tumor biology, 2014-06, Vol.35 (6), p.5647-5651

2014

Volltextzugriff (PDF)

Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis

Respiratory medicine, 2002-08, Vol.96 (8), p.553-558

2002

Volltextzugriff (PDF)

Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma : comparison with Tc-99m methylene diphosphonate

Annals of hematology, 2001-06, Vol.80 (6), p.349-353

2001

Volltextzugriff (PDF)

Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: Correlation with markers of disease activity

American journal of hematology, 2003-04, Vol.72 (4), p.229-233

2003

Volltextzugriff (PDF)

Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myeloma

Medical oncology (Northwood, London, England), 2012-12, Vol.29 (4), p.2396-2401

2012

Volltextzugriff (PDF)

Serum levels of Interleukin-15 and Interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma

Cytokine (Philadelphia, Pa.), 2007-02, Vol.37 (2), p.171-175

2007

Volltextzugriff (PDF)

Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma

Medical oncology (Northwood, London, England), 2013-03, Vol.30 (1), p.363-363, Article 363

2013

Volltextzugriff (PDF)

Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival

Leukemia research, 2004-03, Vol.28 (3), p.259-266

2004

Volltextzugriff (PDF)

The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma

Clinical and laboratory haematology, 2003-02, Vol.25 (1), p.41-46

2003

Volltextzugriff (PDF)

Association between increased levels of IL-2 and IL-15 and outcome in patients with early acute respiratory distress syndrome

European journal of clinical investigation, 2002-11, Vol.32 (11), p.862-867

2002

Volltextzugriff (PDF)

Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis

International journal of immunopathology and pharmacology, 2006-01, Vol.19 (1), p.161-170

2006

Volltextzugriff (PDF)

P046 Abnormal expression of C3ORF9 gene in patients with myelodysplastic syndromes

Leukemia research, 2009-05, Vol.33, p.S85-S85

2009

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Thermal dependence of large-scale freckle defect formation

Potential role of FLT3-ligand in the angiogenic process of multiple myeloma

Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma

Assessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patients

Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma

Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment

B cell-activating factor: its clinical significance in multiple myeloma patients

Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma

Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients

Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma

Activated peripheral blood and endothelial cells in thalassemia patients

The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma

Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity

Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-α in multiple myeloma

Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis

Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma : comparison with Tc-99m methylene diphosphonate

Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: Correlation with markers of disease activity

Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myeloma

Serum levels of Interleukin-15 and Interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma

Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma

Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival

The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma

Association between increased levels of IL-2 and IL-15 and outcome in patients with early acute respiratory distress syndrome

Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis

P046 Abnormal expression of C3ORF9 gene in patients with myelodysplastic syndromes

Suchergebnisse filtern